InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,965.56
(
-0.33%
)
US TECH 100
20,419.60
(
-0.34%
)
Dow Jones
43,819.37
(
-0.32%
)
Brent Oil
72.29
(
0.58%
)
Bitcoin
89,499.20
(
-1.18%
)
Post# of 474050
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

williamssc

Send PM Follow Ignore
Followers 45
Posts 5589
Boards Moderated 0
Alias Born 11/15/2013

williamssc

Re: Diamondhands45 post# 54546

Monday, 02/22/2016 8:39:40 PM

Monday, February 22, 2016 8:39:40 PM

Post# of 474050
Pfizer recently discontinued phase 2 testing of PF-05212377, a 5-HT6 receptor antagonist targeting amyloid plaques being developed for Alzheimer’s Disease. It has been reported that Axovant’s lead drug RVT-101 works by similar MOA.

My posts are my opinion.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM

SANUWAVE Announces Record Quarterly Revenues:  Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

Start posting your company's news
Only $200 per official company press release!